Medical cannabis – time for change
Author:
Open Access
- 1 January 2018
- journal article
- Published by Whitehouse Publishing in Advances in Clinical Neuroscience & Rehabilitation
Abstract
The barriers to use cannabis are breaking down and over 40 countries have legalised the plant for medicinal use.Keywords
This publication has 11 references indexed in Scilit:
- The potential role of cannabinoids in epilepsy treatmentExpert Review of Neurotherapeutics, 2017
- Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic ReviewBiological Psychiatry, 2016
- Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapyCochrane Database of Systematic Reviews, 2015
- Cannabinoids for Medical UseJAMA, 2015
- Endocannabinoids and Their Pharmacological Actions2015
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia PatientsNeuropsychopharmacology, 2011
- Development of a rational scale to assess the harm of drugs of potential misuseThe Lancet, 2007
- Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young peopleBMJ, 2004
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990